Diagnosis of liver metastases from colorectal adenocarcinoma: Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging

Acta Radiologica

Volumn 38, Issue 6, 1997, Pages 986-992

  Strotzer, Michael ^a   Gmeinwieser, J ^a   Schmidt, J ^a   Fellner, C ^a   Seitz, J ^a   Albrich, H ^a   Zirngibl, H ^a   Feuerbach, S ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

CT, helical technology; Iron; Liver neoplasms, diagnosis; MR; Portography

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE; SUPERPARAMAGNETIC IRON OXIDE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLON TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PEROPERATIVE CARE; PORTAL PHLEBOGRAPHY; PROSPECTIVE STUDY; RADIOGRAPHY; RECTUM TUMOR; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SUSPENSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; IMAGE ENHANCEMENT; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE CARE; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PORTOGRAPHY; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE ENHANCEMENT; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SUSPENSIONS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0031279373     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841859709172115     Document Type: Review

References (24)

1. ADSON M. A.: Resection of liver metastases - when is it worthwhile? World J. Surg. 11 (1987), 511.
2. BELLIN M. F., ZAIM S., AUBERTON E. et al.: Liver metastases. Safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 193 (1994), 657.
3. BERRY C. L.: Liver lesions in an autopsy population. Human Toxicol. 6 (1987), 209.
4. FINLAY I. G. & MCARDLE C. S.: Effect of occult hepatic metastases on survival after curative resection for colorectal carcinoma. Gastroenterology 85 (1983), 596.
5. GRANGIER C., TOURNIAIRE J., MENTHA G. et al.: Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J. Comput. Assist. Tomogr. 18 (1994), 888.
6. GREENWAY B.: Hepatic metastases from colorectal cancer: resection or not? Br. J. Surg. 75 (1988), 513.
7. HAGSPIEL K. D., NEIDL K. F. W., EICHENBERGER A. C., WEDER W. & MARINCEK B.: Detection of liver metastases. Comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 196 (1995), 471.
8. HALAVAARA J. T., LAMMINEN A. E., BONDESTAM S., STANDERTSKJÖLD-NORDENSTAM C.-G. & HAMBERG L. M.: Detection of focal liver lesions with superparamagnetic iron oxide. Value of STIR and SE imaging. J. Comput. Assist. Tomogr. 18 (1994), 897.
9. HEIKEN J. P., WEYMAN P. J., LEE J. K. et al.: Detection of focal hepatic masses. Prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 171 (1989), 47.
10. KUSZYK B. S., BLUEMKE D. A., URBAN B. A. et al.: Portal-phase contrast-enhanced helical CT for detection of malignant hepatic tumors. Sensitivity based on comparison with intraoperative and pathologic findings. AJR 166 (1996), 91.
11. MATSUI O., TAKASHIMA T., KADOYA M. et al.: Liver metastases from colorectal cancers. Detection with CT during arterial portography. Radiology 165 (1987), 65.
12. MILLER D. L., SIMMONS J. T., CHANG R. et al.: Hepatic metastases detection. Comparison of three CT contrast enhancement methods. Radiology 165 (1987), 785.
13. MUKAI J. K., STACK C. M., TURNER D. A. et al.: Imaging of surgically relevant hepatic vascular and segmental anatomy. Part 2. Extent and resectability of hepatic neoplasms. AJR 149 (1987), 293.
14. NELSON R. C., CHEZMAR J. L., SUGARBAKER P. H. & BERNARDINO M. E.: Hepatic tumors. Comparison of CT during arterial portography, delayed CT and MR imaging for preoperative evaluation. Radiology 172 (1989), 27.
15. ROS P. R., FREENY P. C., HARMS S. E. et al.: Hepatic MR imaging with ferrum oxides. A multicenter clinical trial of safety and efficacy in the detection of focal hepatic lesions. Radiology 196 (1995), 481.
16. SCHULTZ W. & HORT W.: The distribution of metastases in the liver. A quantitative post-mortem study. Virchows Arch. A. Pathol. Anat. Histopathol. 394 (1981), 89.
17. SENETEREE E., TAOUREL P., BOUVIER Y. et al.: Detection of hepatic metastases. Ferrum-oxide-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200 (1996), 785.
18. SOYER P., BLUEMKE D. A., HRUBAN R. H., SITZMANN J. V. & FISHMAN E. K.: Hepatic metastases from colorectal cancer. Detection and false-positive findings with helical CT during arterial portography. Radiology 193 (1994), 71.
19. SOYER P., LEVESQUE M., ELIAS D., ZEITOUN G. & ROCHE A.: Detection of liver metastases from colorectal cancer. Comparison of intraoperative US and CT during arterial portography. Radiology 183 (1992), 541.
20. TAYLOR P. M., HAWNAUR J. M. & HUTCHINSON C. E.: Superparamagnetic iron oxide imaging of focal liver disease. Clin. Radiol. 50 (1995), 215.
21. VOGL T. J., HAMMERSTINGL R., SCHWARZ W. et al.: Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198 (1996), 881.
22. WAGNER J. S., ADSON M. A., VAN HEERDEN J. A. et al.: The natural history of hepatic metastases from colorectal cancer. Ann. Surg. 199 (1984), 502.
23. WARD B. A., MILLER D. L., FRANCK J. A. et al.: Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases. Correlation with surgical findings. Surgery 105 (1989), 180.
24. WINTER T. C., FREENY P. C., NGHIEM H. V. et al.: MR imaging with i.v. superparamagnetic iron oxide. Efficacy in the detection of focal hepatic lesions. AJR 161 (1993), 1191.